Wow, what is next?
The view from the hill...
May had something to do with the 23 million share dilution, lol...
On April 27, 2016, Gary L. Sender resigned as Chief Financial Officer of Synergy Pharmaceuticals Inc. (the “Company”) for personal reasons, effective April 30, 2016. Bernard F. Denoyer, who has served as Senior Vice President of Finance and Secretary at the Company since 2008, will assume responsibilities as Principal Financial Officer.